Nations Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Buy
2,380
+10
+0.4% +$1.5K 0.02% 602
2026
Q1
$362K Buy
2,370
+314
+15% +$48.1K 0.02% 614
2025
Q4
$284K Buy
2,056
+132
+7% +$17.3K 0.01% 645
2025
Q3
$247K Buy
+1,924
New +$235K 0.02% 631
2023
Q1
Sell
-11,283
Closed -$1.02M 632
2022
Q4
$1.02M Buy
+11,283
New +$950K 0.11% 219
2016
Q4
Sell
-3,245
Closed -$230K 158
2016
Q3
$230K Sell
3,245
-303
-9% -$22.1K 0.23% 137
2016
Q2
$262K Sell
3,548
-222
-6% -$15.3K 0.27% 119
2016
Q1
$245K Buy
3,770
+207
+6% +$14.1K 0.28% 109
2015
Q4
$275K Buy
+3,563
New +$283K 0.36% 87

Other funds holding NVS

Nations Financial Group's NVS Position: Q2 2026 in Review

Nations Financial Group increased its Novartis (NVS) stake by 0.42% in Q2 2026, buying an estimated $1.5K and bringing the position to 2,380 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #602.

Nations Financial Group first reported a position in NVS in Q4 2015 and has held it in 9 quarters since. The position peaked at $1.02M in Q4 2022. 509 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Nations Financial Group held 2,380 shares of Novartis worth $373K as of Q2 2026.
  • Nations Financial Group bought 10 Novartis shares in Q2 2026, an estimated $1.5K.
  • Novartis made up 0.02% of Nations Financial Group's portfolio in Q2 2026, its #602 holding.
  • Nations Financial Group first reported a position in Novartis in Q4 2015 and has held it in 9 quarters since.
  • Nations Financial Group's Novartis position peaked at $1.02M in Q4 2022.
  • 509 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.